HLA class II RFLP-typing in tinea imbricata patients from Papua New Guinea.

Our aim was to examine the HLA-DR and -DQ profiles in tinea imbricata patients and controls from a remote region of Papua New Guinea (where anti-fungal agents are not in use) in order to investigate whether a reduced resistance to T. concentricum could be associated with an MHC class II-directed, or -linked, inability to mount an effective immune response against the fungal agent